We assessed the impact of TRPV3 downregulation on inflammatory mediators, including iNOS and COX-2, in IL-1β-stimulated chondrocytes, as their dysregulation contributes to the pathobiology of osteoarthritis. Here, TRPV3 is linked to osteoarthritis.